The global allergy immunotherapy market is poised for significant growth, with a projected value increase from USD 1.74 billion in 2023 to USD 4.07 billion by 2033, according to a recent report by Future Market Insights (FMI). This impressive growth reflects a robust compound annual growth rate (CAGR) of 8.9% over the next decade.
This expansion is indicative of a rising demand for effective allergy treatments and highlights the increasing adoption of immunotherapy as a viable solution for allergy management.
Key factors driving this market growth include:
- Rising Allergy Burden: The increasing global incidence of allergies, especially complex cases with higher morbidity, is prompting intensified research and development efforts toward innovative treatments.
- Healthcare Advancements: The enhancement of healthcare infrastructure, coupled with the introduction of novel immunotherapeutic drugs, is fueling the expansion of the allergy immunotherapy market.
- Environmental Factors: Escalating levels of air pollution, both indoors and outdoors, have contributed to a surge in asthma and allergy-related respiratory illnesses. According to the Asthma and Allergy Association of America (AAFA), rising pollen levels are responsible for over 25 million allergy cases, underscoring the urgent need for effective treatments.
As the awareness surrounding allergy management continues to grow, patients are increasingly seeking long-term relief from allergic conditions, further driving the market’s growth. The ongoing advancements in treatment methodologies and the rising patient base are pivotal in shaping the future landscape of allergy immunotherapy.
Regional Insights:
Europe and North America currently dominate the Allergy Immunotherapy Market and are expected to maintain significant market shares throughout the forecast period. Europe, in particular, is poised to hold a substantial portion of the market due to increasing awareness, favorable healthcare reimbursement policies, and a growing population of allergy sufferers.
- United Kingdom: Expected to grow at a CAGR of 9.1% through 2033.
- United States: Projected to develop at a 9.1% CAGR during the forecast period.
- Canada: Anticipated to grow rapidly with a CAGR of 9.3%.
- China: Forecasted to increase at a CAGR of 8.8%.
- Germany: Estimated to grow steadily with a CAGR of 9.7% until 2033.
Allergy Immunotherapy Trends Explored: Read Our Full Report for Comprehensive Insights!
Competitive Landscape:
Leading players in the allergy immunotherapy market, including ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, and DBV Technologies, are at the forefront of developing innovative products such as sublingual and subcutaneous immunotherapy. These companies are heavily investing in research and development to enhance the efficacy and safety of existing therapies and to expand their market reach through strategic partnerships and collaborations.
Recent Developments:
- In September 2021, ALK announced plans to expand access to allergy testing, immunotherapy treatments, and adrenaline products by at least 100,000 new patients annually by 2030.
- In June 2021, Stallergenes Greer resumed full production of its subcutaneous allergen immunotherapy (SCIT) product, Alustal®, in Italy and Spain, following a comprehensive restoration of its SCIT manufacturing capabilities.
Market Segmentation:
The Allergy Immunotherapy Market is segmented by product type, immunotherapy type, indication, allergen, distribution channel, and region. Key segments include:
- Product: SLIT Tablets (Odactra, Grastek, Ragwitek, etc.), Oral (Palforzia, Others), Injections, Others.
- Immunotherapy: Sublingual Immunotherapy, Subcutaneous Immunotherapy, Specific Immunotherapy, Others.
- Indication: Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis, Others.
- Allergen: Pollens (Grass, Weed, Tree Pollens), House Dust Mites, Mold, Animal Dander, Bee Venom, Cockroaches/Insects, Others.
- Distribution Channel: Institutional Sales (Government Hospitals, Private Hospitals, etc.), Retail Sales (Retail Pharmacy, Drug Stores, Online Pharmacy).
- Region: North America, Latin America, Europe, South Asia, Oceania, East Asia, Middle East, and Africa.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube